Genomed is a Turkey-based research firm that specializes in molecular diagnosis. Founded in 1992, the company is dedicated to advancing research in molecular diagnosis. Genomed operates in the industries of Digital Health, Health Care, Health and Wellness, and Healthtech. Despite its long history in the field, the company has not disclosed its last investment or the involved investors. Genomed's focus on molecular diagnosis presents opportunities for potential investment and growth in the rapidly evolving digital health and healthcare sectors.
There is no investment information
No recent news or press coverage available for Genomed.